Exact Sciences Corp at Raymond James Institutional Investors Conference Transcript
Good afternoon, everybody. Welcome to -- or thanks for joining us at the Raymond James Institutional Investor Conference. We're happy to have folks from Exact Sciences here with us today.
Nobody wants to hear from me. So I'm just going to sit down and give Kevin a little bit of time with some slides. And then I'll join him again for -- and Megan as well, for some Q&A. Kevin?
Thanks for having us at this great conference. We appreciate the opportunity. Exact Sciences is a cancer diagnostic company. We are the leading cancer diagnostic company at a time that is a very innovative time in the field that's having a huge impact on patient lives.
And our goal as a company is to move detection from late stage to early stage, and we'll talk about the impact. This is our safe harbor. We will be making forward-looking statements. Our mission as a company is to eradicate cancer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |